Synthetic Human Secretin in Children With Autism

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Study Completion Date

January 31, 2004

Conditions
Autism
Interventions
DRUG

RG1068 (Synthetic Human Secretin)

Trial Locations (15)

32607

Alachua Family Psychiatry, Gainesville

43210

The Ohio State University, Columbus

48201

Children's Hospital of Michigan, Detroit

70006

The Clinical Trials Center:A Division of Children's Hospital, Metairie

80112

1st Allergy & Clinical Research Center, Centennial

84093

Children's Biomedical Center of Utah, Sandy City

94609

Children's Hospital and Research Center at Oakland, Oakland

98026

Puget Sound Neurology, Edmonds

Unknown

Southwest Autism Research Center, Phoenix

Miami Children's Hospital, Miami

Hardy Healthcare Associates, Hingham

Schneider Children's Hospital, New Hyde Park

90095-1752

UCLA Pediatric Neurology, Los Angeles

46202-5200

Riley Children's Hospital, Indianapolis

07107

University of Medicine and Dentistry of New Jersey, Newark

All Listed Sponsors
lead

Repligen Corporation

INDUSTRY

NCT00036244 - Synthetic Human Secretin in Children With Autism | Biotech Hunter | Biotech Hunter